HHS partners with hospitals to encourage convalescent plasma donations
The AHA and its members are partnering with the Department of Health and Human Services to encourage eligible patients who recover from COVID-19 to donate convalescent plasma, which contains antibodies that could help other patients fight the virus.
According to recent findings from the Food and Drug Administration’s Expanded Access Program for COVID-19, a study of the first 20,000 adults hospitalized with severe or life-threatening COVID-19 to receive convalescent plasma found the investigational therapy safe in diverse patients.
For more on donating COVID-19 convalescent plasma, visit the FDA’s webpage on donation.
Related News Articles
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…